Having a higher level of cardiorespiratory fitness reduced the risk for cognitive decline and Alzheimer’s, even in people at ...

Stroke was the fourth leading cause of death in the U.S. in 2023, according to the Centers for Disease Control and Prevention ...

The pharmaceutical giant presented mid-stage trial data on the pill, muvalaplin, at the American Heart Association Scientific ...

Zerlasiran was found to be well tolerated and no significant safety concerns were observed. Credit: Good dreams - Studio via ...

Treatment with the Type 2 diabetes medication metformin, lifestyle changes, or a combination of both did not improve atrial ...

Both the nasal and IV forms of bumetanide had a variability in absorption of 27%, suggesting a more stable route of dosing ...

Middle-aged adults with long-term fluctuations in blood pressure may face a higher risk for sudden cardiac death than their ...

Valuable data can successfully be collected with the noninvasive wearable, which is worn on the sternum, report investigators ...

The combination of sacubitril and valsartan reduces the cardiotoxicity related to anthracycline chemotherapy drugs, according ...

What Would They Say?” – the powerful spoken word poem produced on video by the American Heart Association has taken second place in the 4th Annual Anthem Awards winning the Silver Award in the ...

Alva Health is developing a device that uses noninvasive wearables and AI/ML algorithms to monitor the onset of stroke ...

In patients who could not afford new devices on their own, use of so-called "reconditioned" pacemakers met criteria for ...